Advertisement
Screener

LIPOCINE INC. (LPCN) Operating Expenses

2.8 / 5 stars · 68/120 Roast Me

LIPOCINE INC. Operating Expenses

LIPOCINE INC. (LPCN) reported Operating Expenses of $3.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2026-08-04

  • LIPOCINE INC. operating expenses for the quarter ending 2026-06-30 was $3.03M, a 0.17% increase year-over-year.
  • LIPOCINE INC. operating expenses for the quarter ending 2026-03-31 was $3.97M, a 81.72% increase year-over-year.
  • LIPOCINE INC. operating expenses for the quarter ending 2025-12-31 was $3.66M, a 88.15% increase year-over-year.
  • LIPOCINE INC. operating expenses for the quarter ending 2025-09-30 was $3.48M, a 32.13% increase year-over-year.
  • LIPOCINE INC. operating expenses for fiscal 2025 was $12.35M, a 0.04% decline from fiscal 2024.
  • LIPOCINE INC. operating expenses for fiscal 2024 was $12.35M, a 18.08% decline from fiscal 2023.
  • LIPOCINE INC. operating expenses for fiscal 2023 was $15.08M, a 19.50% increase from fiscal 2022.
  • LIPOCINE INC. operating expenses for fiscal 2022 was $12.62M, a 2.89% decline from fiscal 2021.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 6 month as first filedOperating Expenses 9 monthOperating Expenses 9 month as first filedOperating Expenses 12 month
2026-06-30$3.03M
10-Q · filed 2026-08-04
$7.00M
10-Q · filed 2026-08-04
$10.66M
derived: sum of 3 quarters · filed 2026-08-04
$14.14M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$3.97M
10-Q · filed 2026-05-07
$7.63M
derived: sum of 2 quarters · filed 2026-05-07
$11.11M
derived: sum of 3 quarters · filed 2026-05-07
$14.13M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$3.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
$7.14M
derived: sum of 2 quarters · filed 2026-03-10
$10.16M
derived: sum of 3 quarters · filed 2026-08-04
$12.35M
10-K · filed 2026-03-10
2025-09-30$3.48M
10-Q · filed 2025-11-06
$6.50M
derived: sum of 2 quarters · filed 2026-08-04
$8.69M
10-Q · filed 2025-11-06
$10.63M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$3.03M
10-Q · filed 2026-08-04
$5.21M
10-Q · filed 2026-08-04
$7.16M
derived: sum of 3 quarters · filed 2026-08-04
$9.79M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$2.18M
10-Q · filed 2026-05-07
$4.13M
derived: sum of 2 quarters · filed 2026-05-07
$6.76M
derived: sum of 3 quarters · filed 2026-05-07
$10.14M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$1.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10
$4.58M
derived: sum of 2 quarters · filed 2026-03-10
$7.96M
derived: sum of 3 quarters · filed 2026-03-10
$12.35M
10-K · filed 2026-03-10
2024-09-30$2.63M
10-Q · filed 2025-11-06
$6.01M
derived: sum of 2 quarters · filed 2025-11-06
$10.41M
10-Q · filed 2025-11-06
$13.22M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$3.38M
10-Q · filed 2025-08-05
$7.78M
10-Q · filed 2025-08-05
$10.59M
derived: sum of 3 quarters · filed 2025-08-05
$14.51M
derived: sum of 4 quarters · filed 2025-08-05
2024-03-31$4.39M
10-Q · filed 2025-05-08
$7.20M
derived: sum of 2 quarters · filed 2025-05-08
$11.13M
derived: sum of 3 quarters · filed 2025-05-08
$15.08M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31$2.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13
$6.73M
derived: sum of 2 quarters · filed 2025-03-13
$10.69M
derived: sum of 3 quarters · filed 2025-03-13
$15.08M
10-K · filed 2025-03-13
2023-09-30$3.92M
10-Q · filed 2024-11-07
$7.88M
derived: sum of 2 quarters · filed 2024-11-07
$12.27M
10-Q · filed 2024-11-07
$14.83M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$3.96M
10-Q · filed 2024-08-08
$8.35M
10-Q · filed 2024-08-08
$10.91M
derived: sum of 3 quarters · filed 2024-08-08
$13.81M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$4.39M
10-Q · filed 2024-05-09
$6.95M
derived: sum of 2 quarters · filed 2024-05-09
$9.85M
derived: sum of 3 quarters · filed 2024-05-09
$13.88M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$2.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07
$5.46M
derived: sum of 2 quarters · filed 2024-03-07
$9.49M
derived: sum of 3 quarters · filed 2024-03-07
$12.62M
10-K · filed 2024-03-07
2022-09-30$2.90M
10-Q · filed 2023-11-08
$6.93M
derived: sum of 2 quarters · filed 2023-11-08
$10.06M
10-Q · filed 2023-11-08
$13.36M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$4.03M
10-Q · filed 2023-08-10
$7.16M
10-Q · filed 2023-08-10
$10.46M
derived: sum of 3 quarters · filed 2023-08-10
$14.05M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$3.13M
10-Q · filed 2023-05-11
$6.43M
derived: sum of 2 quarters · filed 2023-05-11
$10.02M
derived: sum of 3 quarters · filed 2023-05-11
$13.01M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$3.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10
$6.89M
derived: sum of 2 quarters · filed 2023-03-10
$9.88M
derived: sum of 3 quarters · filed 2023-03-10
$13.00M
10-K · filed 2023-03-10
2021-09-30$3.59M
10-Q · filed 2022-11-09
$6.58M
derived: sum of 2 quarters · filed 2022-11-09
$9.69M
10-Q · filed 2022-11-09
$14.50M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$2.99M
10-Q · filed 2022-08-08
$6.10M
10-Q · filed 2022-08-08
$10.91M
derived: sum of 3 quarters · filed 2022-08-08
$15.28M
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31$3.11M
10-Q · filed 2022-05-09
$7.92M
derived: sum of 2 quarters · filed 2022-05-09
$12.29M
derived: sum of 3 quarters · filed 2022-05-09
$16.51M
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31$4.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09
$9.18M
derived: sum of 2 quarters · filed 2022-03-09
$13.40M
derived: sum of 3 quarters · filed 2022-03-09
$18.00M
10-K · filed 2022-03-09
2020-09-30$4.38M
10-Q · filed 2021-11-10
$8.60M
derived: sum of 2 quarters · filed 2021-11-10
$13.19M
10-Q · filed 2021-11-10
$16.64M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$4.22M
10-Q · filed 2021-08-05
$8.82M
10-Q · filed 2021-08-05
$12.27M
derived: sum of 3 quarters · filed 2021-08-05
$15.41M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31$4.60M
10-Q · filed 2021-05-06
$8.05M
derived: sum of 2 quarters · filed 2021-05-06
$11.19M
derived: sum of 3 quarters · filed 2021-05-06
$14.54M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31$3.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
$6.59M
derived: sum of 2 quarters · filed 2021-03-11
$9.94M
derived: sum of 3 quarters · filed 2021-03-11
$13.07M
10-K · filed 2021-03-11
2019-09-30$3.14M
10-Q · filed 2020-11-10
$6.49M
derived: sum of 2 quarters · filed 2020-11-10
$9.62M
10-Q · filed 2020-11-10
$9.62M
10-Q · filed 2019-11-12
$12.79M
derived: sum of 4 quarters · filed 2020-11-10
2019-06-30$3.35M
10-Q · filed 2020-08-06
$6.48M
10-Q · filed 2020-08-06
$6.48M
10-Q · filed 2019-08-07
$9.65M
derived: sum of 3 quarters · filed 2020-08-06
$12.00M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$3.13M
10-Q · filed 2020-05-07
$3.13M
10-Q · filed 2019-05-08
$6.30M
derived: sum of 2 quarters · filed 2020-05-07
$8.65M
derived: sum of 3 quarters · filed 2020-05-07
$11.81M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$3.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$5.52M
derived: sum of 2 quarters · filed 2020-03-13
$8.69M
derived: sum of 3 quarters · filed 2020-03-13
$11.75M
10-K · filed 2020-03-13
2018-09-30$2.35M
10-Q · filed 2019-11-12
$5.52M
derived: sum of 2 quarters · filed 2019-11-12
$8.58M
10-Q · filed 2019-11-12
$13.98M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$3.16M
10-Q · filed 2019-08-07
$3.16M
10-Q · filed 2018-08-07
$6.23M
10-Q · filed 2019-08-07
$11.63M
derived: sum of 3 quarters · filed 2019-08-07
$16.40M
derived: sum of 4 quarters · filed 2019-08-07
2018-03-31$3.07M
10-Q · filed 2019-05-08
$8.47M
derived: sum of 2 quarters · filed 2019-05-08
$13.23M
derived: sum of 3 quarters · filed 2019-05-08
$19.37M
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31$5.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
$10.17M
derived: sum of 2 quarters · filed 2019-03-06
$16.31M
derived: sum of 3 quarters · filed 2019-03-06
$21.22M
10-K · filed 2019-03-06
2017-09-30$4.77M
10-Q · filed 2018-11-07
$10.91M
derived: sum of 2 quarters · filed 2018-11-07
$15.82M
10-Q · filed 2018-11-07
$18.83M
derived: sum of 4 quarters · filed 2019-03-06
2017-06-30$6.14M
10-Q · filed 2018-08-07
$11.05M
10-Q · filed 2018-08-07
$14.06M
derived: sum of 3 quarters · filed 2019-03-06
$17.35M
derived: sum of 4 quarters · filed 2019-03-06
2017-03-31$4.91M
10-Q · filed 2018-05-07
$7.92M
derived: sum of 2 quarters · filed 2019-03-06
$11.21M
derived: sum of 3 quarters · filed 2019-03-06
$17.03M
derived: sum of 4 quarters · filed 2019-03-06
2016-12-31$3.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06
$6.30M
derived: sum of 2 quarters · filed 2019-03-06
$12.12M
derived: sum of 3 quarters · filed 2019-03-06
$19.19M
10-K · filed 2019-03-06
2016-09-30$3.29M
10-Q · filed 2017-11-08
$9.10M
derived: sum of 2 quarters · filed 2017-11-08
$16.17M
10-Q · filed 2017-11-08
$20.87M
derived: sum of 4 quarters · filed 2018-03-12
2016-06-30$5.82M
10-Q · filed 2017-08-07
$12.89M
10-Q · filed 2017-08-07
$17.58M
derived: sum of 3 quarters · filed 2018-03-12
$24.02M
derived: sum of 4 quarters · filed 2018-03-12
2016-03-31$7.07M
10-Q · filed 2017-05-08
$11.77M
derived: sum of 2 quarters · filed 2018-03-12
$18.20M
derived: sum of 3 quarters · filed 2018-03-12
$22.48M
derived: sum of 4 quarters · filed 2018-03-12
2015-12-31$4.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
$11.13M
derived: sum of 2 quarters · filed 2018-03-12
$15.41M
derived: sum of 3 quarters · filed 2018-03-12
$18.38M
10-K · filed 2018-03-12
2015-09-30$6.43M
10-Q · filed 2016-11-08
$10.71M
derived: sum of 2 quarters · filed 2016-11-08
$13.69M
10-Q · filed 2016-11-08
$17.75M
derived: sum of 4 quarters · filed 2017-03-06
2015-06-30$4.28M
10-Q · filed 2016-08-09
$7.25M
10-Q · filed 2016-08-09
$11.31M
derived: sum of 3 quarters · filed 2017-03-06
$15.43M
derived: sum of 4 quarters · filed 2017-03-06
2015-03-31$2.97M
10-Q · filed 2016-05-09
$7.03M
derived: sum of 2 quarters · filed 2017-03-06
$11.15M
derived: sum of 3 quarters · filed 2017-03-06
$18.16M
derived: sum of 4 quarters · filed 2017-03-06
2014-12-31$4.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06
$8.18M
derived: sum of 2 quarters · filed 2017-03-06
$15.19M
derived: sum of 3 quarters · filed 2017-03-06
$20.48M
10-K · filed 2017-03-06
2014-09-30$4.12M
10-Q · filed 2015-11-12
$11.13M
derived: sum of 2 quarters · filed 2015-11-12
$16.42M
10-Q · filed 2015-11-12
$20.83M
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30$7.01M
10-Q · filed 2015-08-11
$12.30M
10-Q · filed 2015-08-11
$16.71M
derived: sum of 3 quarters · filed 2015-08-11
$20.26M
derived: sum of 4 quarters · filed 2015-08-11
2014-03-31$5.29M
10-Q · filed 2015-05-07
$9.71M
derived: sum of 2 quarters · filed 2015-05-07
$13.25M
derived: sum of 3 quarters · filed 2015-05-07
$14.62M
derived: sum of 4 quarters · filed 2015-05-07
2013-12-31$4.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11
$7.96M
derived: sum of 2 quarters · filed 2015-03-11
$9.33M
derived: sum of 3 quarters · filed 2015-03-11
$10.68M
10-K · filed 2015-03-11
2013-09-30$3.55M
10-Q · filed 2014-11-10
$4.92M
derived: sum of 2 quarters · filed 2014-11-10
$6.27M
10-Q · filed 2014-11-10
2013-06-30$1.37M
10-Q · filed 2014-08-13
$2.73M
10-Q · filed 2014-08-13
2013-03-31$1.35M
10-Q · filed 2014-05-13
2012-12-31$3.83M
10-K · filed 2014-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Rocket One Inc. (RKTO)United States$0.019B
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03